Subinhibitory Concentrations of Cefpodoxime Alter Membrane Protein Expression of Actinobacillus Actinomycetemcomitans and Enhance Its Susceptibility to Killing by Neutrophils

Overview

Journal Antimicrob Agents Chemother

Publisher American Society for Microbiology

Specialty Pharmacology

Date 1995 Feb 1

PMID 7726506

Citations 1

Authors

P J Baker

W F Busby

M E Wilson

Affiliations

Soon will be listed here.

Abstract

The aim of the present study was to determine the effect of the antibiotic cefpodoxime on the gram-negative periodontopathic microorganism Actinobacillus actinomycetemcomitans and its interaction with elements of the host immune system. Growth of A. actinomycetemcomitans in subinhibitory concentrations of cefpodoxime induced morphological changes in the bacteria, causing the organisms to grow as filaments rather than coccobacilli. Growth in cefpodoxime did not render these bacteria susceptible to killing by serum, nor did it abrogate the requirement for serum opsonins to support the bactericidal activity of neutrophils. Cefpodoxime enhanced the susceptibility of A. actinomycetemcomitans to the bactericidal activity of neutrophils. In the presence of suitable opsonins, neutrophils were able to kill four times as many cefpodoxime-induced A. actinomycetemcomitans filaments as untreated A. actinomycetemcomitans CFU. This effect was due to antibiotic actions on the bacterium and not on the neutrophil. At inhibitory concentrations, the bactericidal activities of cefpodoxime and neutrophils were additive, and cefpodoxime did not interfere with the normal functioning of the neutrophils. Concomitant with these morphological and functional changes, the expression of two outer membrane proteins (66 and 29 kDa) and one inner membrane protein (57 kDa) was decreased in A. actinomycetemcomitans grown in cefpodoxime. The concentration range over which cefpodoxime is effective against A. actinomycetemcomitans in vivo may be extended by the ability of subinhibitory concentrations to enhance the susceptibility of this organism to host immune defenses.

Citing Articles

Mature Biofilm Degradation by Potential Probiotics: Aggregatibacter actinomycetemcomitans versus Lactobacillus spp.

Jaffar N, Ishikawa Y, Mizuno K, Okinaga T, Maeda T PLoS One. 2016; 11(7):e0159466.

PMID: 27438340 PMC: 4954673. DOI: 10.1371/journal.pone.0159466.

References

Genco R . Antibiotics in the treatment of human periodontal diseases. J Periodontol. 1981; 52(9):545-58. DOI: 10.1902/jop.1981.52.9.545. View

Sader H, Jones R, Washington J, Murray P, Gerlach E, Allen S . In vitro activity of cefpodoxime compared with other oral cephalosporins tested against 5556 recent clinical isolates from five medical centers. Diagn Microbiol Infect Dis. 1993; 17(2):143-50. DOI: 10.1016/0732-8893(93)90025-3. View

Atkinson B, Amaral L . Sublethal concentrations of antibiotics, effects on bacteria and the immune system. Crit Rev Microbiol. 1982; 9(2):101-38. DOI: 10.3109/10408418209104487. View

Sundqvist G, Johansson E . Bactericidal effect of pooled human serum on Bacteroides melaninogenicus, Bacteroides asaccharolyticus and Actinobacillus actinomycetemcomitans. Scand J Dent Res. 1982; 90(1):29-36. DOI: 10.1111/j.1600-0722.1982.tb01521.x. View

Mandell L . Effects of antimicrobial and antineoplastic drugs on the phagocytic and microbicidal function of the polymorphonuclear leukocyte. Rev Infect Dis. 1982; 4(3):683-97. DOI: 10.1093/clinids/4.3.683. View

Miller D, Lamster I, Chasens A . Role of the polymorphonuclear leukocyte in periodontal health and disease. J Clin Periodontol. 1984; 11(1):1-15. DOI: 10.1111/j.1600-051x.1984.tb01303.x. View

Genco R, Slots J . Host responses in periodontal diseases. J Dent Res. 1984; 63(3):441-51. DOI: 10.1177/00220345840630031601. View

Zambon J . Actinobacillus actinomycetemcomitans in human periodontal disease. J Clin Periodontol. 1985; 12(1):1-20. DOI: 10.1111/j.1600-051x.1985.tb01348.x. View

Baker P, Evans R, Slots J, Genco R . Antibiotic susceptibility of anaerobic bacteria from the human oral cavity. J Dent Res. 1985; 64(10):1233-44. DOI: 10.1177/00220345850640101201. View

10.

Watanabe Y, Tawara S, Mine Y, Kikuchi H, Goto S, Kuwahara S . Synergism of cephalosporins at subinhibitory concentrations and polymorphonuclear leukocytes on phagocytic killing of Escherichia coli and its mode of action. J Antibiot (Tokyo). 1986; 39(2):294-303. DOI: 10.7164/antibiotics.39.294. View

11.

Slots J, Bragd L, Wikstrom M, Dahlen G . The occurrence of Actinobacillus actinomycetemcomitans, Bacteroides gingivalis and Bacteroides intermedius in destructive periodontal disease in adults. J Clin Periodontol. 1986; 13(6):570-7. DOI: 10.1111/j.1600-051x.1986.tb00849.x. View

12.

HOROWITZ E, Pugsley M, Turbes P, Clark R . Pericarditis caused by Actinobacillus actinomycetemcomitans. J Infect Dis. 1987; 155(1):152-3. DOI: 10.1093/infdis/155.1.152. View

13.

Jones R, Barry A . Antimicrobial activity and disk diffusion susceptibility testing of U-76,253A (R-3746), the active metabolite of the new cephalosporin ester, U-76,252 (CS-807). Antimicrob Agents Chemother. 1988; 32(4):443-9. PMC: 172198. DOI: 10.1128/AAC.32.4.443. View

14.

Pruul H, McDonald P . Damage to bacteria by antibiotics in vitro and its relevance to antimicrobial chemotherapy: a historical perspective. J Antimicrob Chemother. 1988; 21(6):695-8. DOI: 10.1093/jac/21.6.695. View

15.

Baker P, Wilson M . Effect of clindamycin on neutrophil killing of gram-negative periodontal bacteria. Antimicrob Agents Chemother. 1988; 32(10):1521-7. PMC: 175911. DOI: 10.1128/AAC.32.10.1521. View

16.

Baker P, Wilson M . Opsonic IgG antibody against Actinobacillus actinomycetemcomitans in localized juvenile periodontitis. Oral Microbiol Immunol. 1989; 4(2):98-105. DOI: 10.1111/j.1399-302x.1989.tb00106.x. View

17.

Watanabe H, Marsh P, Ivanyi L . Antigens of Actinobacillus actinomycetemcomitans identified by immunoblotting with sera from patients with localized human juvenile periodontitis and generalized severe periodontitis. Arch Oral Biol. 1989; 34(8):649-56. DOI: 10.1016/0003-9969(89)90020-4. View

18.

Dubreuil L, Derriennic M, SEDALLIAN A . [Comparative antibacterial activity of cefpodoxime, cefuroxime and cefaclor against strict anaerobic bacteria]. Pathol Biol (Paris). 1990; 38(5):343-6. View

19.

Darveau R, Cunningham M . Influence of subinhibitory concentrations of cephalosporins on the serum sensitivity of Pseudomonas aeruginosa. J Infect Dis. 1990; 162(4):914-21. DOI: 10.1093/infdis/162.4.914. View

20.

Arbo A, Mancilla J, Alpuche C, Santos J . In vitro and in vivo effects of subinhibitory concentrations of clindamycin on experimental Klebsiella pneumoniae sepsis. Chemotherapy. 1990; 36(5):337-44. DOI: 10.1159/000238786. View